Article Information
History
- February 23, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hiam Chemaitelly, PhD1,*,
- Peter Coyle, MD2,
- Mohamed Ali Ben Kacem, MD2,
- Houssein H. Ayoub, PhD3,
- Patrick Tang, MD PhD4,
- Mohammad R. Hasan, PhD5,
- Hadi M. Yassine, PhD3,
- Asmaa A. Al Thani, PhD3,
- Zaina Al-Kanaani, PhD2,
- Einas Al-Kuwari, MD2,
- Andrew Jeremijenko, MD2,
- Anvar H. Kaleeckal, MSc2,
- Ali N. Latif, MD2,
- Riyazuddin M. Shaik, MSc2,
- Hanan F. Abdul-Rahim, PhD3,
- Gheyath K. Nasrallah, PhD3,
- Mohamed Ghaith Al-Kuwari, MD6,
- Adeel A. Butt, MBBS MS2,
- Hamad E. Al-Romaihi, MD7,
- Mohamed H. Al-Thani, MD7,
- Abdullatif Al-Khal, MD2,
- Roberto Bertollini, MD MPH7 and
- Laith J. Abu-Raddad, PhD1,*
- 1Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
- 2Hamad Medical Corporation, Doha, Qatar
- 3Qatar University, Doha, Qatar
- 4Sidra Medicine, Doha, Qatar
- 5McMaster University, Hamilton, Canada
- 6Primary Health Care Corporation, Doha, Qatar
- 7Ministry of Public Health, Doha, Qatar
- ↵*Correspondence to Dr. Hiam Chemaitelly, E-mail: hsc2001{at}qatar-med.cornell.edu or Professor Laith J. Abu-Raddad, E-mail: lja2002{at}qatar-med.cornell.edu.
Posted February 23, 2024.
Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant
